China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
China Resources Pharmaceutical Group Ltd. has entered into a new Business Travel Services Framework Agreement with CR Digital, effective from January 2025 to December 2027, to update annual transaction caps. This agreement, involving connected transactions under Hong Kong’s Listing Rules, allows the company to leverage CR Digital’s online travel platform for various services without needing independent shareholder approval.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.